Unither invests $106m in Monroe County NY facility modernisation
Paris, June 3, 2024. BIOPHTA, a preclinical biotech company developing a game-changing technologynfor the treatment of eye diseases, has just closed a € 6.5 million Seed round to bring its patentedntechnology to clinical development. This funding round was led by leading European VCs –nUI Investissement (via the Pertinence Invest 2 Fund, advised by Mérieux Equity Partners), Elaia andnGO Capital – as well as one major ophthalmology player, Unither Pharmaceuticals andnHTL Biotechnology, the global leader in production and development of pharma grade biopolymers.
Official launch of the CURECALL solution to ophthalmologists in France!
The pharmaceutical company Delpharm has appointed Alain Kirchmeyer to the position of managing director.
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. & ROCK HILL, S.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that in partnership with 3D Systems Corporation (NYSE: DDD) it has produced the world’s most complex 3D-printed object – a human lung scaffold – and demonstrated it at the LIFE ITSELF Conference that occurred May 31 to June 3, 2022 in San Diego. The event was organized and hosted by Dr. Sanjay Gupta and Marc Hodosh and was sponsored by CNN, United Therapeutics, and other prominent corporate leaders in healthcare.
Abstract Background: The use of paracetamol or nefopam for postoperative pain control is limited by the need of high doses associated with unwanted effects. Previous works suggest positive interactions between both compounds that may be exploited to obtain potentiation of antinociception.
The resurgence of certain respiratory diseases like asthma, which are linked to allergy factors, requires the prescription of inhaled treatments that are effective for patients of various types, as well as sustainable in terms of their carbon footprint..
The key to success? Sharing ideas with partners to create innovative ophthalmological products
Stéphane Bourillot? No one is more entitled than his teams to talk about him. For that matter, they did so through internal surveys carried out by Unither. Rarely has one of the group’s plants had such good scores and such good feedback. Clearly, Gannat is a great place to work. And, without a doubt, it is one of Stéphane Bourillot’s greatest sources of pride. This passionate rugby fan acts both as the director of the site and as the team captain. His aim is to instill strong motivation and one shared objective among the complete workforce: customer satisfaction.
In strong growth for several years, the Unither laboratory in Coutances is launching three new production runs between 2021 and 2022 and intends to recruit more than 70 people.